Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart
- First Online:
- 289 Downloads
Cancer pain (CP) management is challenging. In recent years, efforts were undertaken to achieve better CP management, e.g. clinical research, new treatment modalities, development of guidelines, education and focus on implementation. The aim of the present study was to compare the prevalence and characteristics of pain and breakthrough pain (BTP) between cross-sectional studies conducted in 2008 and 2014. It was hypothesized that an improvement in pain control would be observed the years in between.
Two cross-sectional studies were conducted where adult cancer patients answered questions from Brief Pain Inventory and the Alberta Breakthrough Pain Assessment Tool for cancer patients. Physicians reported socio-demographic and medical data. Regression models were applied for analysis.
In total, 168 inpatients, 92 in 2008 and 76 in 2014, and 675 outpatients, 301 in 2008 and 374 in 2014, were included. The patient characteristics of the samples were comparable. Prevalence of CP among inpatients was 55 % in 2008 and 53 % in 2014, and among outpatients, 39 and 35 %, respectively. Inpatients reported average pain intensity (0–10 numerical rating scale, NRS) of 3.60 (standard deviation, SD 1.84) (2008) and 4.08 (SD 2.11) (2014); prevalence of BTP was 52 % (2008) and 41 % (2014). For outpatients, average pain intensity was 3.60 (SD 2.04) (2008) and 3.86 (SD 2.20) (2014); prevalence of BTP was 43 % (2008) and 37 % (2014). None of the differences were statistically significant.
Unexpectedly, no improvement in pain control was observed. Efforts are still needed to improve cancer pain management.
KeywordsCancer Pain management BTP Implementation Breakthrough pain Cross-sectional study Prevalence
- 1.Donaldson N, Joranson D, Sbanotto A, Teoh N, Twycross R, Ventafridda V. Cancer pain relief. Cancer pain relief. second edition ed. Genova: World Health Organisation (WHO); 1996. p. 1–36.Google Scholar
- 14.Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G (2013) Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom ManageGoogle Scholar
- 20.(2013) Directorate of Health: Nasjonalt handlingsprogram med retningslinjer for palliasjon i kreftomsorgen [Norwegian guidelines for palliative care]. IS-2101Google Scholar
- 22.Norwegian Ministry of Health and Care Services: the coordination reform. Report No. 47. 2008–2009.Google Scholar
- 25.Karnofsky DA, Burchenal J (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of chemotherapeutic agents. Columbia Univ Press; p. 196.Google Scholar
- 28.Te Boveldt N, Vernooij-Dassen M, Burger N, Ijsseldijk M, Vissers K, Engels Y (2013) Pain and its interference with daily activities in medical oncology outpatients. Pain Physician 16(4):379–89Google Scholar
- 33.Te Boveldt N, Vernooij-Dassen M, Besse K, Vissers K, Engels Y (2014) Adoptation of an evidence-based clinical practice guideline in cancer pain management by medical oncologists: a case vignette study. Support Care CancerGoogle Scholar
- 41.omsorgsdepartementet H-o. Sammen mot kreft, Nasjonal kreftstrategi 2013–2017 [21.05 2015]. Available from: https://www.regjeringen.no/contentassets/07cd14ff763444a3997de1570b85fad1/kreftstrategien_2013.pdf.
- 42.Brusamento S, Legido-Quigley H, Panteli D, Turk E, Knai C, Saliba V et al (2012) Assessing the effectiveness of strategies to implement clinical guidelines for the management of chronic diseases at primary care level in EU Member States: a systematic review. Health Policy 107(2–3):168–83CrossRefPubMedGoogle Scholar